GIE Medical, Inc.

Brooklyn Park, MN · Founded 2018 · Medtech · Acquired

Endoscopic device for treating benign esophageal and bowel strictures

Claim this profile

Follows are private to you and power your alerts

Updated · giemedical.com

Sector
Medtech
Headquarters
Brooklyn Park, MN
Founded
2018
Latest Form D
$5M, Sep 2023
Total capital
$18M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$18M
3 Form D · last Sep 2023
37 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
2 pending · first 2026
Rank in peer group#498 of 1112

Capital timeline

201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $18M1st Form D$2M2nd Form D$11M3rd Form D$5M
201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $18M1st Form D$2M2nd Form D$11M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$5M
  • Private capital raisedForm D · SEC · 2nd filing$11M
  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#498 · top 45%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Lixiao WangResearcherExecutive Officer, Director, PromoterLinked by 1 patent
  • Hui HuDirectorNamed in SEC Form D filings
  • Ling ShangDirectorNamed in SEC Form D filings
  • Ouyang XiangyuDirectorNamed in SEC Form D filings
  • Rushu LuoDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 3
  • GrantedPolymer-encapsulated Drug ParticlesUSPTOUS 12,605,342
  • PendingPolymer-encapsulated Drug ParticlesUSPTOApplication 18955058
  • PendingPolymer-encapsulated Drug ParticlesUSPTOApplication PCTUS2021018823
  • CYTORECOVERY, INC.Similar federal contract value in Medtech · null in contracts
  • PATHY MEDICAL LLCSimilar federal contract value in Medtech · null in contracts
  • Reperio Health, Inc.Similar federal contract value in Medtech · null in contracts
  • SENSEWHY, INC.Similar federal contract value in Medtech · null in contracts
  • Noleus Technologies, Inc.Similar federal contract value in Medtech · null in contracts
  • Nia Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .